跳至主要内容
临床试验/NCT02511587
NCT02511587已完成4 期

Comparison of Vaccination Routes: Subcutaneous Versus Intramuscular Application of FSME-Immun®

Medical University of Vienna0 个研究点目标入组 116 人开始时间: 2012年10月最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
116
主要终点
Humoral Immunity to TBE (Tick-borne Encephalitis) Vaccine

研究概览

简要总结

FSME-Immun® is registered for application into the muscle. This study investigates if application under the skin leads to a comparable immune response.

详细描述

Tick-borne encephalitis (TBE) vaccine (FSME-Immun®) is registered for intra-muscular application. Due to medical reasons (e.g. anticoagulant therapy, adipositas) intra-muscular application is not always possible. The aim of this clinical trial is to investigate whether a comparably good immunogenicity can be achieved via the subcutaneous vaccination route. Thus humoral and cellular immune responses after intramuscular and subcutaneous TBE vaccination in healthy volunteers will be compared.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • completed primary TBE immunization + at least one booster immunization
  • adults of both sexes between 18 and 60 years of age
  • willingness to sign written informed consent form

排除标准

  • age < 18 and > 60 years
  • prior TBE infection
  • pregnancy and breast feeding
  • acute infection on day of inclusion (day 0), (body temperature > 37,9°C)
  • concomitant medications: systemic cortisone therapy, chemotherapy, immunosuppressive therapy 4 weeks prior to or during study
  • administration of other vaccines 4 weeks before/after day 0
  • planned surgery within 2 weeks before/after TBE booster vaccination
  • specific immunotherapy (Hypo-/Desensibilisation) 14 days before/after vaccination
  • any contraindication to administration of FSME-Immun® vaccine according to manufacturer's instructions
  • history of malignant disease within the last 5 years
  • autoimmune diseases
  • drug addictions
  • plasma donors
  • receipt of blood transfusions or immuno globulins within 3 month before study entry

研究组 & 干预措施

intra muscular application

Active Comparator

intra muscular application of FSME-Immune vaccination

干预措施: FSME-Immune vaccination (Biological)

subcutaneous application

Experimental

subcutaneous application of FSME-Immune vaccination

干预措施: FSME-Immune vaccination (Biological)

结局指标

主要结局

Humoral Immunity to TBE (Tick-borne Encephalitis) Vaccine

时间窗: 1 month

GMT (geometric mean titers) of TBE Neutralisation test titers one month after booster vaccination

次要结局

  • TBE Titer Profile(before (day 0) and 1week, 1 month, 6 months after booster vaccination)
  • Cellular Immune Responses - Cytokines(before (day 0) and 1 week after booster vaccination)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Univ. Prof. Dr. Ursula Wiedermann

Univ.-Prof. Dr. Ursula Wiedermann

Medical University of Vienna

相似试验